Royalty Pharma plc
Pablo G. Legorreta (CEO, Chairman of the Board) reports RPRX insider transactions
AI-generated summary
Pablo G. Legorreta, CEO, Chairman of the Board, Director of Royalty Pharma plc Class A Ordinary Shares, received 42,209 shares as a grant on November 4, 2026. Following this transaction, the insider directly holds 1,350,029 shares.
Key facts
- Insider
- Pablo G. Legorreta · CEO, Chairman of the Board, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | A · grantFootnotes F1 | +42,209 | $0.00 | $0.00 | 1,350,029 | Direct |
Footnotes
- F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
Remarks: In addition to the Class A Ordinary Shares disclosed above, the Reporting Person and family vehicles controlled by the Reporting Person hold 73,195,660 Class B Ordinary Shares exchangeable into 73,195,660 Class A Ordinary Shares and 13,356,742 Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 13,356,742 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.
More RPRX filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- SC 13G/A
Filed Nov 5, 2026
- 10-Q
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.